State of the art in the clinical treatment of endotoxic shock

Antonio Artigas, Pasquale Piccinni

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Sepsis is a major health problem and remains an important cause of death worldwide. The failure to convert advances in our understanding of the biologic features of sepsis into effective new therapies questions the current approach to the development of sepsis drugs, and suggests a need for newer and better clinical trial design. Blood purification for sepsis is a promising therapeutic strategy to improve survival and reduce organ failure in patients with severe sepsis and septic shock. © 2014 S. Karger AG, Basel.
Original languageEnglish
Pages (from-to)2-4
JournalBlood Purification
Volume37
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 10 Feb 2014

Keywords

  • Polymyxin B hemoperfusion
  • Sepsis
  • Surviving Sepsis Campaign

Fingerprint Dive into the research topics of 'State of the art in the clinical treatment of endotoxic shock'. Together they form a unique fingerprint.

  • Cite this